Comparison of the anti-inflammatory and anti-nociceptive effects of cortistatin-14 and somatostatin-14 in distinct in vitro and in vivo model systems

Journal of Molecular Neuroscience

Volumn 46, Issue 1, 2012, Pages 40-50

  Markovics, Adrienn ^a   Szőke, Éva ^a   Sándor, Katalin ^a   Börzsei, Rita ^a   Bagoly, Teréz ^a   Kemény, Ágnes ^a   Elekes, Krisztián ^a   Pintér, Erika ^a,b   Szolcsányi, János ^a,b   Helyes, Zsuzsanna ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b PharmInVivo Ltd   (Hungary)

Author keywords

Calcitonin gene related peptide; Carrageenan; Edema; G protein activation; Inflammatory cytokines; Mechanical and thermal hyperalgesia; Neurogenic inflammation; Somatostatin 1 and 4 receptors

Indexed keywords

CALCITONIN; CAPSAICIN; CARRAGEENAN; CORTISTATIN; CORTISTATIN 14; ENDOTOXIN; INTERLEUKIN 1BETA; PENTOBARBITAL; PLASMA PROTEIN; SOMATOSTATIN 14; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG POTENCY; FEMALE; HYPERALGESIA; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; MUSTARD; NERVE ENDING; NONHUMAN; PAW EDEMA; PERIPHERAL NERVE; PERITONEUM MACROPHAGE; RAT;

MURINAE; RATTUS;

EID: 84858802112     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9577-4     Document Type: Article

References (54)

1. Banks WA, Schally AV, Barrera CM, Fasold MB, Durham DA, Csernus V, Groot K, Kastin A (1990) Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc Natl Acad Sci USA 87:6762-6766
2. Bojnik E, Magyar A, Tóth G, Bajusz S, Borsodi A, Benyhe S (2009) Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences. Neuroscience 158(2):867-874
3. Bölcskei K, Horvath D, Szolcsanyi J, Petho G (2007) Heat injury-induced drop of the noxious heat threshold measured with an increasing-temperature water bath: a novel rat thermal hyperalgesia model. Eur J Pharmacol 564:80-87 (Pubitemid 46946845)
4. Broglio F, Koetsveld Pv P, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Gauna C, Hofland L, Deghenghi R, Arvat E, Van Der Lely AJ, Ghigo E (2002) Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 87(10):4829-4832 (Pubitemid 35247084)
5. Capuano A, Currò D, Navarra P, Tringali G (2011) Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. Peptides 32 (1):138-143
6. Carlton SM, Du J, Zhou S, Coggeshall RE (2001a) Tonic control of peripheral cutaneous nociceptors by somatostatin receptors. J Neurosci 21(11):4042-4049 (Pubitemid 32466495)
7. Carlton SM, Du J, Davidson E, Zhou S, Coggeshall RE (2001b) Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors. Pain 90(3):233-244 (Pubitemid 32162945)
8. Criado JR, Li H, Jiang X, Spina M, Huitrón-Reséndiz S, Liapakis G, Calbet M, Siehler S, Henriksen SJ, Koob G, Hoyer D, Sutcliffe JG, Goodman M, de Lecea L (1999) Structural and compositional determinants of cortistatin activity. J Neurosci Res 56 (6):611-619 (Pubitemid 29246843)
9. Dalm VA, van Hagen PM, van Koetsveld PM, Langerak AW, van der Lely AJ, Lamberts SW, Hofland LJ (2003a) Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. J Clin Endocrinol Metab 88(1):270-276 (Pubitemid 36115177)
10. Dalm VA, van Hagen PM, van Koetsveld PM, Achilefu S, Houtsmuller AB, Pols DH, van der Lely AJ, Lamberts SW, Hofland LJ (2003b) Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 285(2):E344-E353 (Pubitemid 36899708)
11. Dalm VA, Hofland LJ, Ferone D, Croxen R, Lamberts SW, van Hagen PM (2003c) The role of somatostatin and somatostatin analogs in the pathophysiology of the human immune system. J Endocrinol Invest 26(8 Suppl):94-102
12. Delgado M, Ganea D (2008) Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain Behav Immun 22(8):1146-1151
13. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ (2001) A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106(5):619-632 (Pubitemid 32879323)
14. Elekes K, Helyes Z, Kereskai L, Sandor K, Pinter E, Pozsgai G, Tekus V, Benvolgyi A, Nemeth J, Szuts T, Keri G, Szolcsenyi J (2008) Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse. Eur J Pharmacol 578(2-3):313-322
15. Engström M, Tomperi J, El-Darwish K, Åhman M, Savola JM, Wurster S (2005) Superagonism at the human somatostatin receptor subtype 4. J Pharmacol Exp Ther 312:332-338 (Pubitemid 40096486)
16. Engström M, Savola JM, Wurster S (2006) Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses. J Pharmacol Exp Ther 316:1262-1268 (Pubitemid 43345302)
17. Ferone D, Boschetti M, Resmini E, Giusti M, Albanese V, Goglia U, Albertelli M, Vera L, Bianchi F, Minuto F (2006) Neuroendocrineimmune interactions: the role of cortistatin/somatostatin system. Ann N YAcad Sci 1069:129-144 (Pubitemid 43989856)
18. Gamse R, Leeman SE, Holzer P, Lembeck F (1981) Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous systemof the rat. Naunyn Schmiedebergs Arch Pharmacol 317(2):140-148 (Pubitemid 11060723)
19. Gilligan JP, Lovato SJ, Erion MD, Jeng AY (1994) Modulation of carrageenan-induced hind paw edema by substance P. Inflammation 18:285-292 (Pubitemid 24232680)
20. Gonzalez-Rey E, Delgado M (2008) Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders. Mol Cell Endocrinol 286(1-2):135-140 (Pubitemid 351680232)
21. Gonzalez-Rey E, Chorny A, Robledo G, Delgado M (2006a) Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med 203(3):563-571
22. Gonzalez-Rey E, Varela N, Sheibanie AF, Chorny A, Ganea D, Delgado M (2006b) Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc Natl Acad Sci USA 103(11):4228-4233
23. Gonzalez-Rey E, Chorny A, Del Moral RG, Varela N, Delgado M (2007) Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Ann Rheum Dis 66(5):582-588 (Pubitemid 46707125)
24. Helyes Z, Nemeth J, Pinter E, Szolcsanyi J (1997) Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol 121:613-615 (Pubitemid 27260761)
25. Helyes Z, Than M, Oroszi G, Pinter E, Nemeth J, Keri G et al (2000) Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci Lett 278:185-188 (Pubitemid 30009488)
26. Helyes Z, Pinter E, Nemeth J, Keri G, Than M, Oroszi G et al (2001) Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br J Pharmacol 134:1571-1579 (Pubitemid 33131909)
27. Helyes Z, Szabo A, Nemeth J, Jakab B, Pinter E, Banvolgyi A et al (2004) Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat. Arthritis Rheum 50:1677-1685 (Pubitemid 38608091)
28. Helyes Z, Pinter E, Nemeth J, Sandor K, Elekes K, Szabo A, Pozsgai G, Keszthelyi D, Kereskai L, Engström M, Wurster S, Szolcsanyi J (2006) Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents. Br J Pharmacol 149(4):405-415 (Pubitemid 44582247)
29. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP et al (1995) Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16:86-88
30. Kang JS, Jeon YJ, Kim HM, Han SH, Yang K-H (2002) Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 302:138-144 (Pubitemid 34680431)
31. Karalis K, Mastorakos G, Chrousos GP, Tolis G (1994) Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest 93:2000-2006 (Pubitemid 24143079)
32. Lecea L, del Rio JA, Criado JR, Alcántara S, Morales M, Danielson PE, Henriksen SJ, Soriano E, Sutcliffe JG (1997) Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci 17(15):5868-5880 (Pubitemid 27310501)
33. Lembeck F, Donnerer J, Bartho L (1982) Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide. Eur J Pharmacol 85:171-176 (Pubitemid 13223226)
34. Méndez-Díaz M, Guevara-Martínez M, Alquicira CR, Guzmán Vásquez K, Prospéro-García O (2004) Cortistatin, a modulatory peptide of sleep and memory, induces analgesia in rats. Neurosci Lett 354(3):242-244
35. Nemeth J, Helyes Z, Gorcs T, Gardi J, Pinter E, Szolcsanyi J (1996) Development of somatostatin radioimmunoassay for the measurement of plasma and tissue contents of hormone. Acta Physiol Hung 84:313-315 (Pubitemid 126476425)
36. Nemeth J, Gorcs T, Helyes Z, Oroszi G, Kocsy T, Pinter E et al (1998) Development of a new sensitive CGRP radioimmunoassay for neuropharmacological research. Neurobiology (Budapest) 6:473-475 (Pubitemid 29185179)
37. Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20(3):157-198
38. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB (1995) The somatostatin receptor family. Life Sci 57:1249-1265
39. Pinter E, Helyes Z, Nemeth J, Porszasz R, Petho G, Than M et al (2002) Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol 366:142-150 (Pubitemid 34762274)
40. Pinter E, Helyes Z, Szolcsanyi J (2006) Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112(2):440-456 (Pubitemid 44508773)
41. Ramírez JL, Mouchantaf R, Kumar U, Otero Corchon V, Rubinstein M, Low MJ, Patel YC (2002) Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. Mol Endocrinol 16 (8):1951-1963 (Pubitemid 34828101)
42. Reisine T, Bell GI (1995) Molecular properties of somatostatin receptors. Neuroscience 67:777-790
43. Robas N, Mead E, Fidock M (2003) MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 278(45):44400-44404 (Pubitemid 37377189)
44. Rubio A, Avila J, de Lecea L (2007) Cortistatin as a therapeutic target in inflammation. Expert Opin Ther Targets 11(1):1-9 (Pubitemid 46099749)
45. Schindler M, Humphrey PP, Emson PC (1996) Somatostatin receptors in the central nervous system. Prog Neurobiol 50(1):9-47 (Pubitemid 26362570)
46. Siehler S, Seuwen K, Hoyer D (1998) [125I]Tyr10-cortistatin14 labels all five somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol 357(5):483-489
47. Siehler S, Nunn C, Hannon J, Feuerbach D, Hoyer D (2008) Pharmacological profile of somatostatin and cortistatin receptors. Mol Cell Endocrinol 286(1-2):26-34
48. Spier AD, de Lecea L (2000) Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 33(2-3):228-241
49. Szolcsanyi J (2004) Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38:377-384
50. Szolcsanyi J, Helyes Z, Oroszi G, Nemeth J, Pinter E (1998a) Release of somatostatin and its role in the mediation of the antiinflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 123:936-942 (Pubitemid 28085395)
51. Szolcsanyi J, Pinter E, Helyes Z, Oroszi G, Nemeth J (1998b) Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol 125:916-922 (Pubitemid 28482638)
52. ten Bokum AM, Hofland LJ, Van Hagen PM (2000) Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw 11:161-176
53. Tostivint H, Joly L, Lihrmann I, Parmentier C, Lebon A, Morisson M, Calas A, Ekker M, Vaudry H (2006) Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. PNAS 103:2237-2242 (Pubitemid 43271653)
54. Vinegar R, Truax JF, Selph JL, Johnston PR, Venable AL, McKenzie KK (1987) Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc 46:118-126